Fundraising Fox
T Therapeutics
Cambridge, GB · 64 employees on LinkedIn · 7 known investors
Find your way into T Therapeutics
Sign up to see every warm intro you have to T Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the T Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs. The company combines expertise in biopharmaceutical drug development, single cell genomics, machine learning, and structural biology.
Investors · 7
How we know: a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: F-Prime Capital's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does T Therapeutics do?
- T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs. The company combines expertise in biopharmaceutical drug development, single cell genomics, machine learning, and structural biology.
- Who are T Therapeutics's investors?
- T Therapeutics's investors include Cambridge Innovation Capital, F-Prime Capital, Sanofi Ventures, Sofinnova Partners, Business Growth Fund, Digitalis Ventures, University of Cambridge Enterprise.
- Where is T Therapeutics headquartered?
- T Therapeutics is headquartered in Cambridge, GB.